Company intelligence / Profile preview

Tryton Medical

Durham, North Carolina, United Statestrytonmedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Tryton Medical developed the first and only FDA-approved dedicated bifurcated stent system—the Tryton Side Branch Stent—designed to treat complex coronary artery bifurcation lesions. The device has demonstrated superior procedural and device success compared to provisional strategies in a landmark multinational pivotal trial with over 700 patients. Additional registry studies have confirmed these results, supporting predictable outcomes and broadening access globally.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

PTV Sciences (investor)RiverVest Venture Partners (investor)Spray Venture Partners (investor)3x5 Special Opportunity Fund (investor)

Beyond the preview

Go deeper on Tryton Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tryton Medical.

Explore the full profile